Evidence map›Paper›PMID 40740481›Full record

ArticleMolecular neurodegeneration advances2025

Uncovering plaque-glia niches in human Alzheimer's disease brains using spatial transcriptomics.

Denis R Avey, Bernard Ng, Ricardo A Vialle, Nicola A Kearns, Katia de Paiva Lopes, Artemis Iatrou, Sashini De Tissera, Himanshu Vyas, Devin M Saunders, Daniel J Flood and 5 more

Abstract read
In one paragraph

Article in Molecular neurodegeneration advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Spatial architecture of development and disease.Nature reviews. Genetics · 2026
    Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Denis R Avey *Present Address: Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL 60612 USA.
Bernard Ng *Present Address: Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL 60612 USA.
Ricardo A Vialle *Present Address: Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL 60612 USA.
Nicola A KearnsPresent Address: Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL 60612 USA.
Katia de Paiva LopesPresent Address: Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL 60612 USA.
Artemis IatrouPresent Address: Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL 60612 USA.
Sashini De TisseraPresent Address: Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL 60612 USA.
Himanshu VyasPresent Address: Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL 60612 USA.
Devin M SaundersPresent Address: Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL 60612 USA.
Daniel J FloodPresent Address: Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL 60612 USA.
Jishu XuPresent Address: Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL 60612 USA.
Shinya TasakiPresent Address: Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL 60612 USA.
Chris GaiteriPresent Address: Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL 60612 USA.
David A BennettPresent Address: Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL 60612 USA.
Yanling WangPresent Address: Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL 60612 USA.

Funding

SUPPLEMENT TO RUSH ALZHEIMERS DISEASE CENTER COREP30AG010161 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1991 to 2020
$49.1M
Uncovering cell-type-specific driver genes of Alzheimer's Disease by pathology-indexing scRNA-seq, spatial transcriptomics, and CRISPR screensR01AG074082 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI Yanling Wang · 2022 to 2026
$3.6M
NIA NIH HHS P30 AG010161NIA NIH HHS R01 AG074082
6 · The paper itself

Abstract

Background: Amyloid-beta (Aβ) plaques and their associated glial responses are hallmark features of Alzheimer's disease (AD), yet their interactions within the human brain remain poorly defined. Methods: We applied spatial transcriptomics (ST) and immunohistochemistry (IHC) to 78 postmortem brain sections from 21 individuals in the Religious Orders Study and Memory and Aging Project (ROSMAP). We paired ST with histological data and stratified spots into major categories of plaque-glia niches based on Aβ, GFAP, and IBA1 intensity. Leveraging published ROSMAP single-nucleus RNA-seq data, we examined differences in gene expression, cellular composition, and intercellular communication across these niches. Neuronal and glial changes were validated by IHC and quantitative analyses. We further characterized glial responses using gene set enrichment analysis (GSEA) with known mouse glial signatures and human AD-associated microglial states. Finally, we used iPSC-derived multicellular cultures and single-cell RNA sequencing (scRNA-seq) to identify cell types that, upon short-term Aβ exposure, recapitulate the glial responses observed in the human spatial data. Results: Low-Aβ regions, enriched for diffuse plaques, exhibited transcriptomic profiles consistent with greater neuronal loss than high-Aβ regions. High-glia regions showed increased expression of inflammatory and neurodegenerative pathways. Spatial glial responses aligned with established gene modules, including plaque-induced genes (PIGs), oligodendrocyte (OLIG) responses, disease-associated microglia (DAM), disease-associated astrocytes (DAA), and human AD-associated microglial states, indicating that diverse glial phenotypes emerge around plaques and shape the local immune environment. IHC confirmed elevated neuronal apoptosis near low-Aβ plaques and greater CD68 abundance and synaptic loss near glia-high plaques. In vitro, iPSC-derived microglia-but not astrocytes-exposed to Aβ displayed transcriptomic changes that closely mirrored the glial states identified in our ST dataset. Conclusions: Our study provides a comprehensive spatial transcriptomic dataset from human AD brain tissue and bridges spatial gene expression with traditional neuropathology. By integrating ST, snRNA-seq, and human multicellular models, we map cellular states and molecular events within plaque-glia niches. This work offers a spatially resolved framework for dissecting plaque-glia interactions and reveals new insights into the cellular and molecular heterogeneity underlying neurodegenerative pathology. Supplementary Information: The online version contains supplementary material available at 10.1186/s44477-025-00002-z.

Indexed as

Alzheimer’s DiseaseAmyloid-betaGliaHuman BrainSpatial Transcriptomics

Identifiers

PMID40740481
PMCPMC12310243

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.